Archives

How SARS-CoV-2 evades our immune system

Scientists at Hokkaido University and Texas A&M University have identified a key mechanism used by the SARS-CoV-2 virus to evade host immune systems.

Researchers in Japan and the United States have found SARS-CoV-2 can knock out an important molecular pathway linked to an immune complex called MHC class I.

Read More

CBD Infused Products Popularity Rising Fast in Over-the-counter Retail Stores

As medical and recreational legalization of cannabis continues to make cannabis products more mainstream, more consumers are shifting their views on the plant, and retailers are taking notice. Cannabis — and, in particular, cannabidiol (CBD), is poised to become one of the most popular and financially successful sectors of consumer processed goods.…

Read More

HempFusion® Participates and Sponsors Industry Leading Study on CBD and Human Health

HempFusion® (“the Company”), a leading dietary supplements company focused on products that contain Hemp/CBD in the United States with distribution of its family of brands to approximately 4,000 retailers across 47 states, is pleased to announce the sponsorship and participation in ValidCare’s scientific study that addresses the Food and Drug Administration’s (“FDA”) previous questions about CBD products.…

Read More

Encore Life, LLC and WholeScripts, LLC Announce Partnership Agreement

TULSA, Okla., June 1, 2020 /PRNewswire/ — Encore Life, the only practitioner-exclusive professional grade Hemp supplement manufacturer, and WholeScripts, powered by XYMOGEN, the fastest growing supplier of nutritional supplements, have signed a partnership agreement naming Encore Life as the premier Hemp Extract product line offered via WholeScripts’ sales channels.…

Read More

The Hemp Doctor: How Did CBD Become Popular to Americans?

CBD has already gone from being a “trend” to a lifestyle norm for many, as the booming CBD product market continues to surge and doting reviews keep customers coming back for more.

Prior to 2018, many Americans would have probably had to ask their smartphones or their favorite search engine to define those three now very familiar letters: CBD.…

Read More

Congress Makes Move to Allow CBD in Food and Beverages

It appears consumers are not the only group losing patience with the FDA’s progress on CBD legalization. On January 13th, 2020, a bipartisan bill to amend the Federal Food, Drug and Cosmetic Act (FD&C Act) regarding cannabidiol (CBD) and CBD containing substances was introduced in the U.S.…

Read More

Research shows real risks associated with cannabis exposure during pregnancy

A new study from researchers at Western University and Queen’s University definitively shows that regular exposure to THC, the main psychoactive ingredient in cannabis, during pregnancy has significant impact on placental and fetal development. With more than a year since the legalization of recreational cannabis in Canada, the effects of its use during pregnancy are only now beginning to be understood.…

Read More

InMed First to Advance Cannabinol (CBN) into Therapeutic Clinical Trials

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing therapeutics targeting diseases with high unmet medical needs, today revealed the rare cannabinoid  cannabinol (“CBN”) as the active pharmaceutical ingredient (“API”) in its two product candidates under development: INM-755 for epidermolysis bullosa (“EB”) and INM-088 for glaucoma.…

Read More